SCHEMBL2013738

SCHEMBL2013738

NCCc1cc(Cl)c2cccnc2c1N1CCC(Oc2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.39
KDM4E B2RXH2 6/20 0.39
MAPT P10636 5/20 0.39
LMNA P02545 5/20 0.39
TDP1 Q9NUW8 5/20 0.39
RAB9A P51151 4/20 0.39
NPSR1 Q6W5P4 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
MAPK1 P28482 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
NOD2 Q9HC29 1/20 0.39
CHRM4 P08173 1/20 0.39
METAP2 P50579 3/20 0.39
HTT P42858 5/20 0.38
HRH1 P35367 1/20 0.38
CCR3 P51677 1/20 0.38
KCNH2 Q12809 1/20 0.38
SLC40A1 Q9NP59 1/20 0.37
NPC1 O15118 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011771 0.87 METAP2 (0.41) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2013467 0.85 SMN1; SMN2 (0.41) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2019128 0.84 METAP2 (0.44) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2017653 0.83 METAP2 (0.40) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2015395 0.82 MAPT (0.44) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2018108 0.82 METAP2 (0.38) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2018508 0.82 KDM4E (0.43) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2012282 0.81 MAPT (0.40) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2015070 0.81 METAP2 (0.40) SMN1; SMN2KDM4EMAPTLMNATDP1
SCHEMBL2012338 0.81 KDM4E (0.42) SMN1; SMN2KDM4EMAPTLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed